SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Labwire Inc. – ‘1-A’ on 4/21/23 – ‘EX1K-12 OPN CNSL’

On:  Friday, 4/21/23, at 11:18am ET   ·   Accession #:  1376474-23-253   ·   File #:  24-12230

Previous ‘1-A’:  None   ·   Next:  ‘1-A/A’ on 5/18/23   ·   Latest:  ‘1-A/A’ on 6/15/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/21/23  Labwire Inc.                      1-A                   10:6.7M                                   Advanced Compute… Inc/FA

Offering Statement   —   Form 1-A   —   Regulation A/A+

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-A         Offering Statement -- primary_doc.xml               HTML     13K 
 2: PART II AND III  Offering Circular                              HTML    576K 
 3: EX1A-2A CHARTER  Articles of Incorporation/Organization         HTML      7K 
 4: EX1A-2B BYLAWS  Restated Bylaws                                 HTML      6K 
 5: EX1A-3 HLDRS RTS  Series A Cod                                  HTML      5K 
 6: EX1A-4 SUBS AGMT  Subscriptiion Agreement                       HTML     37K 
 8: EX1A-6 MAT CTRCT  Consulting Agreement                          HTML     58K 
 9: EX1A-6 MAT CTRCT  Consulting Agreement                          HTML     58K 
 7: EX1A-6 MAT CTRCT  Convertible Note                              HTML    105K 
10: EX1K-12 OPN CNSL  Legal Opinion and Conselt                     HTML      9K 


‘EX1K-12 OPN CNSL’   —   Legal Opinion and Conselt


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 
  Legal Opinion and Conselt  

Exhibit 12.1

 

 

Jeffrey Turner – Attorney at Law

897 Baxter Drive

So. Jordan, Utah 84095

(801) 810-4465

Admitted in the State of Utah

 

April 19, 2023

 

Shin Hwang

Chief Executive Officer

LABWIRE, INC.

6015 N 43rd Ave

Phoenix, AZ 85019

 

Dear Mr. Hwang:

 

I have acted, at your request, as special counsel to Labwire, Inc., a Nevada corporation (the “Company”), for the purpose of rendering an opinion as to the legality of 800,000,000 shares of Company common stock, par value $0.001, offered by the Company at a price range of $0.005-$0.02 per share of Company common stock to be offered and distributed by Company (the “Shares”), pursuant to a Tier 1 Offering Statement filed under Regulation A of the Securities Act of 1933, as amended, by Company with the U.S. Securities and Exchange Commission (the "SEC") on Form 1-A, for the purpose of registering the offer and sale of the Shares (“Offering Statement”).

 

In rendering this opinion, I have reviewed (a) statutes of the State of Nevada, to the extent I deem relevant to the matter opined upon herein; (b) true copies of the Articles of Incorporation of Company and all amendments thereto; (c) the By-Laws of Company; (d) selected proceedings of the board of directors of Company authorizing the issuance of the Shares; (e) certificates of officers of Company and of public officials; (f) and such other documents of Company and of public officials as I have deemed necessary and relevant to the matter opined upon herein.

 

I have assumed (a) the Offering Statement filed on Form 1-A and all corresponding exhibits (collectively, the "Documents") have been duly authorized and executed (except as it relates to the Company in which case the Documents have in fact been duly authorized and executed); (b) the persons who executed the Documents had the legal capacity to do so; and (c) the persons identified as officers are actually serving as such and that any shares issued under and pursuant to the Offering Statement will be properly authorized by one or more such persons.

 

Based upon my review described herein, it is my opinion the Shares are duly authorized and when/if issued and delivered by Company against payment therefore, as described in the offering statement, will be validly issued, fully paid, and non-assessable.


I have not been engaged to examine, nor have I examined, the Offering Statement for the purpose of determining the accuracy or completeness of the information included therein or the compliance and conformity thereof with the rules and regulations of the SEC or the requirements of Form 1-A, and I express no opinion with respect thereto. The forgoing opinion is strictly limited to matters of Nevada corporation law; and I do not express an opinion on the federal law of the United States of America or the law of any state or jurisdiction therein other than Nevada, as specified herein.

 

I hereby consent to the filing of this opinion as Exhibit 12.1 to the Offering Statement and to the reference to our firm under the caption “Legal Matters” in the Offering Circular constituting a part of the Offering Statement. We assume no obligation to update or supplement any of the opinion set forth herein to reflect any changes of law or fact that may occur following the date hereof.

 

 

Sincerely,

 

JDT LEGAL, PLLC

 

 

/s/ Jeffrey Turner

Jeffrey Turner


Dates Referenced Herein

This ‘1-A’ Filing    Date    Other Filings
Filed on:4/21/23None on these Dates
4/19/23
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/15/23  Labwire Inc.                      1-A/A                  2:629K                                   Advanced Compute… Inc/FA
 6/01/23  SEC                               UPLOAD7/28/23    2:43K  Labwire Inc.
 5/18/23  Labwire Inc.                      1-A/A                  3:680K                                   Advanced Compute… Inc/FA
 5/03/23  SEC                               UPLOAD7/28/23    2:44K  Labwire Inc.
Top
Filing Submission 0001376474-23-000253   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 11:50:31.1am ET